Spectrum of complex chromosomal aberrations in a myelodysplastic syndrome and a brief review
- PMID: 28054536
- DOI: 10.4103/0973-1482.197563
Spectrum of complex chromosomal aberrations in a myelodysplastic syndrome and a brief review
Abstract
Myelodysplastic syndrome (MDS) is a heterogeneous premalignant condition characterized by cytopenia, ineffective hematopoiesis, dysplastic marrow, and risk of progression to acute myeloid leukemia. Cytogenetic abnormalities, including del(3q/5q/7q/11q/12p/20q), monosomy 5/7, trisomy 8/19, i(17q), and -Y, are the indicators of diagnosis and risk stratification. The present case with bicytopenia detected with highly complex chromosome rearrangements with variability in numerical and structural combinations. Chromosome analysis was carried out following unstimulated marrow culture and G-banding. In addition to known MDS-aberrations, der(9p), der(12) dic(12;?19), +15, -18, and ring and marker chromosomes were recorded having, at least, nine abnormal chromosomes/cell. To our knowledge, this is the first case with all MDS-aberrations in one single individual. The case has been discussed in relevance to current MDS research. In the present case, i(17q)/-17, der(12p), del(5q26), del(7q36), and del(20q11) indicate possible alterations in TP53, ETV6, IDH2, EZH2, and SRSF2 genes, which are responsible for pathomechanism, genetic instability, clonal evolution, and advancement of disease condition.
Similar articles
-
Cytogenetic findings in primary and secondary MDS.Leuk Res. 1992;16(1):43-6. doi: 10.1016/0145-2126(92)90098-r. Leuk Res. 1992. PMID: 1732669 Review.
-
Impact of chromosome alterations, genetic mutations and clonal hematopoiesis of indeterminate potential (CHIP) on the classification and risk stratification of MDS.Blood Cells Mol Dis. 2018 Mar;69:90-100. doi: 10.1016/j.bcmd.2017.10.001. Epub 2017 Oct 16. Blood Cells Mol Dis. 2018. PMID: 29079134 Review.
-
Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia.Leuk Res. 2000 Oct;24(10):839-48. doi: 10.1016/s0145-2126(00)00056-4. Leuk Res. 2000. PMID: 10996202
-
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.Leukemia. 1993 Sep;7(9):1315-23. Leukemia. 1993. PMID: 8371581
-
FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q).Leuk Res. 2010 Apr;34(4):447-53. doi: 10.1016/j.leukres.2009.08.023. Epub 2009 Sep 15. Leuk Res. 2010. PMID: 19758696 Free PMC article.
Cited by
-
Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility.Oncol Rev. 2019 Feb 4;13(1):389. doi: 10.4081/oncol.2019.389. eCollection 2019 Jan 14. Oncol Rev. 2019. PMID: 30858933 Free PMC article.
-
Techniques for detecting chromosomal aberrations in myelodysplastic syndromes.Oncotarget. 2017 May 9;8(37):62716-62729. doi: 10.18632/oncotarget.17698. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977983 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous